Individualization of immunosuppressive therapy: I. Sirolimus improves outcomes in African-American renal transplant recipients

Transplantation Proceedings

Volumn 37, Issue 9, 2005, Pages 3723-3726

  Podder, H ^a   Kahan, B D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; OKT 3; PREDNISONE; RAPAMYCIN; THYMOCYTE ANTIBODY;

AFRICAN AMERICAN; ANEMIA; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REACTION TIME; RECIPIENT; RISK ASSESSMENT; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AFRICAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MUROMONAB-CD3; SIROLIMUS; SURVIVAL ANALYSIS; TEXAS; TIME FACTORS; TREATMENT OUTCOME;

EID: 29544450035     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.10.090     Document Type: Conference Paper

References (23)

1. M.J. Cecka, P.I. Terasaki P.I. Terasaki J.M. Cecka Clinical Transplants 1995 UCLA Los Angeles, Calif p1
2. A.G. Diethelm, E.H. Blackstone, D.C. Naftel Important risk factors al allograft survival in cadaveric renal transplantation a study of 426 patients Ann Surg 207 1988 538
3. J. Dunn, A. Vathsala, D. Golden Impact of race on the outcome of renal transplantation under cyclosporine-prednisone Transplant Proc 21 1989 3946
4. H.J. Ward, M. Koyle, P.I. Terasaki Outcome of renal transplantation in blacks Transplant Proc 19 1987 1546
5. M.R. First, T.J. Schroeder, A.P. Monaco Cyclosporine bioavailability dosing implications and impact on clinical outcomes in select transplantation subpopulations Clin Transplant 10 1996 55
6. J.F. Neylan Immunosuppressive therapy in high-risk transplant patients Transplantation 64 1997 1277
7. J.F. Neylan Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine Transplantation 65 1998 515
8. J.A. Light, J.L. Kelly, A. Aquino Improving renal transplant outcomes in African-Americans with OKT3 induction therapy Transplant Proc 25 1993 2436
9. R.H. Didlake, K.K. Dreyfus, R.H. Kerman Patient noncompliance a major cause of late graft failure in cyclosporine-treated renal transplants Transplant Proc 20 1988 63
10. D.E. Butkus, E.F. Meydrech, S.S. Raju Racial differences in the survival of cadaveric renal allograft overriding effects of HLA matching and socioeconomic factors N Engl J Med 327 1992 840
11. B.D. Kahan, N. Tejpal, S. Gibbons-Stubbers The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination Transplantation 55 1993 894
12. H. Podder, J. Podbielski, I. Hussein Sirolimus improves the two-year outcome of renal allografts in African-American patients Transplant Int 14 2001 135
13. B.D. Kahan, M. Welsh, L.P. Rutzky Challenges in cyclosporine therapy the role of therapeutic drug monitoring by area under the curve monitoring Ther Drug Monit 17 1995 621
14. B. Kaplan, H.U. Meier-Kriesche, K.L. Napoli The effects of relative timing of sirolimus and cyclosporine microemulsion formulation co-administration on the pharmacokinetics of each agent Clin Pharmacol Ther 63 1998 48
15. B. Browne, B.D. Kahan B.D. Kahan Surgical Clinics of North America Horizons in Transplantation 1994 Saunders Philadelphia 1097
16. P.A. Kelly, K.L. Napoli, C. Dunne Conversion from liquid to solid sirolimus formulations in stable renal allograft transplant recipients Biopharm Drug Dispos 20 1999 249
17. B.D. Kahan, J. Podbielski, K.L. Napoli Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation Transplantation 66 1998 1040
18. L.C. Racusen, K. Solez, R.B. Colvin The Banff 97 working classification of renal allograft pathology Kidney Int 55 1999 713
19. From the Centers for Disease Control and Prevention West Nile virus infection in organ donor and transplant recipients - Georgia and Florida, 2002 JAMA 288 2002 1465
20. R.S. Gaston, S.L. Hudson, M.H. Deierhoi Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression Transplantation 53 1992 103
21. D.E. Hricik, H.A. Anton, T.C. Knauss Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids Transplantation 74 2002 189
22. B.L. Kasiske, K.L. Tortorice, K.L. Heim-Duthoy The adverse impact of cyclosporine on serum lipids in renal transplant recipients Am J Kidney Dis 17 1991 700
23. B.D. Kahan The role of rapamycin in chronic rejection prophylaxis a theoretical consideration Graft 1 2 suppl II 1998 93